Search results
Results from the WOW.Com Content Network
If you had an actual time machine and bought in pre-pandemic on March 1, 2020, you’d have paid $29.95 per share and could have converted a $1,000 investment into $7,802.52 today. Pfizer
J&JPRD was created in 2001 through the merging of various research organizations including McNeil Pharmaceuticals, Janssen Research Foundation, Three Dimensional Pharmaceuticals, and the R. W. Johnson Pharmaceutical Research Institute.
For the fiscal year 2023, Johnson & Johnson reported earnings of $35.15 billion, with an annual revenue of $85.16 billion, an increase of 10.57% over the previous fiscal cycle. Johnson & Johnson's shares traded at over $160 per share, and its market capitalization was valued at over $386.7 billion in July 2024.
Cerenovus Nimbus [10] Cerebase DA Guide Sheath [11] Trufill n-BCA Liquid Embolic System [12] Orthopedics (DePuy Synthes) Velys Digital Surgery platform [13] Attune Cementless Fixed Bearing Knee [14] Actis Hip Stem [15] Inhance Shoulder System [16] Dynatape Suture [17] Trumatch Graft Cage [18] Symphony OCT System [19] Surgery Vicryl [20]
A good way to close out the fiscal year. In the quarter, Johnson Controls managed to boost its sales by 7% year over year; they landed at $7.4 billion. ... $1.24 per share. Johnson controls put a ...
In Johnson Controls' first fiscal quarter of 2014 it posted a 5% increase in sales to $10.9 billion. The company's segment Why Would Johnson Controls' Share Price Drop After a Surge in Earnings?
By Steven Brill Letter From the Editors Backstage at Johnson & Johnson. On May 20, about 100 stock analysts gathered in the ballroom of the Hyatt Regency Hotel in New Brunswick, New Jersey, to hear good news from top executives at Johnson & Johnson: The company had 10 new drugs in the pipeline that might achieve more than a billion dollars in annual sales.
In September 2016, pharmaceutical and medical device company Johnson & Johnson announced they were buying Abbott Medical Optics for $4.3 billion. [13] On February 27, 2017, Abbott Medical Optics changed its name to Johnson & Johnson Vision following its $4.3 billion acquisition by Johnson & Johnson. [14] In 2017, JJV acquired TearScience. [15]